Mirae Asset Global Etfs Holdings Ltd. Actinium Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 14,643 shares of ATNM stock, worth $26,650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,643Holding current value
$26,650% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ATNM
# of Institutions
76Shares Held
7.05MCall Options Held
96.6KPut Options Held
70.5K-
Black Rock Inc. New York, NY1.88MShares$3.41 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.48MShares$2.69 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA666KShares$1.21 Million0.0% of portfolio
-
State Street Corp Boston, MA610KShares$1.11 Million0.0% of portfolio
-
Marshall Wace, LLP London, X0256KShares$465,9670.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $45.8M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...